Literature DB >> 24580393

Copper removal strategies for Wilson's disease crisis in the ICU.

H V Reynolds1, C R Talekar, J Bellapart, B A Leggett, R J Boots.   

Abstract

Wilson's disease is a rare, inherited, autosomal recessive disorder of copper metabolism which leads to an accumulation of copper in body tissues. If a patient develops a Wilson's crisis, mortality can approach 100%. The treatment of such patients is mostly organ support but a possible treatment goal is to try to rapidly remove copper from their system. We performed a literature search on methods for de-coppering strategies for patients in intensive care with known Wilson's disease. We found 11 case reports where therapeutic plasma exchange was used and six case reports where various forms of albumin dialysis were used as techniques for rapidly reducing serum copper levels. To date, the case reports are encouraging that therapeutic plasma exchange and albumin dialysis can either delay or prevent the need for liver transplantation in patients with fulminant hepatic failure due to Wilson's disease. However, these case reports are mainly in the paediatric or young adult population, thus further studies in adults are warranted.

Entities:  

Keywords:  Wilson’s disease; albumin dialysis; copper; haemolysis; molecular absorbent recirculating system; plasma exchange

Mesh:

Substances:

Year:  2014        PMID: 24580393

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

1.  Report of the ASFA apheresis registry study on Wilson's disease.

Authors:  Huy P Pham; Joseph Schwartz; Laura Cooling; Jan C Hofmann; Haewon C Kim; Shanna Morgan; Monica B Pagano; Jennifer Schneiderman; Jeffrey L Winters; Chisa Yamada; Edward C C Wong; Yanyun Wu
Journal:  J Clin Apher       Date:  2015-08-14       Impact factor: 2.821

2.  Total Biosynthesis and Diverse Applications of the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin.

Authors:  Mahmoud Kamal Ahmadi; Samar Fawaz; Charles H Jones; Guojian Zhang; Blaine A Pfeifer
Journal:  Appl Environ Microbiol       Date:  2015-05-29       Impact factor: 4.792

3.  Therapies for ataxias.

Authors:  Laurence Martineau; Anne Noreau; Nicolas Dupré
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

Review 4.  The Role of Zinc in the Treatment of Wilson's Disease.

Authors:  Abolfazl Avan; Anna Członkowska; Susan Gaskin; Alberto Granzotto; Stefano L Sensi; Tjaard U Hoogenraad
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.